RENITEC

This brand name is authorized in Austria, Australia, Brazil, Ecuador, Estonia, Spain, Finland, France, Netherlands, New Zealand, Romania, South Africa

Active ingredients

The drug RENITEC contains one active pharmaceutical ingredient (API):

1 Enalapril
UNII 9O25354EPJ - ENALAPRIL MALEATE

Enalapril is hydrolysed via hepatic CES 1 to the active metabolite enalaprilat, which acts as an ACE inhibitor. ACE is a peptidyl dipeptidase which catalyses the conversion of angiotensin I to the vasoconstrictor substance angiotensin II and hence inhibition of ACE results in decreased plasma angiotensin II. This also leads to increased plasma renin activity and decreased aldosterone secretion. The mechanism of action of enalapril is therefore primarily via the suppression of the RAAS. However, ACE is identical to kininase II, and so enalapril may also exert its effects by blocking the degradation of bradykinin, a potent vasodepressor peptide.

Read about Enalapril

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RENITEC Tablet Pharmaceutical Benefits Scheme (AU) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C09AA02 Enalapril C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1368B, 1369C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 525501901113314, 525501903116310, 525501904112319
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 367200813
Country: EE Ravimiamet Identifier(s): 1074215, 1074226, 1074259, 1371080
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 57768, 57773
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 091686
Country: FR Base de données publique des médicaments Identifier(s): 64371242, 68128273
Country: NL Z-Index G-Standaard, PRK Identifier(s): 21075
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 13617, 3449, 3450
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68244001, W68245001, W68246001
Country: ZA Health Products Regulatory Authority Identifier(s): T/7.1.3/164, T/7.1.3/165, T/7.1.3/166

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.